Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter sales VYVGART impact continues with approximately 19 ...

Marketing Tech Platform Expands Capabilities Across Turnkey In-Game Activations, Loyalty Mechanics and Campaign Measurement ...

In 2023, the DVV partnered with the ITP student team to envision the future of public services in 2040. The project aimed to explore potential scenarios for Finland and DVV, considering the impact of ...

ITP is a living community of technologists, theorists, engineers, designers, and artists dedicated to pushing the boundaries of interactivity in the real and digital worlds. Approach the challenges of ...

Aalto University Information Technology Program (ITP) is a minor study module (24 ECTS) for a wide variety of bright university students. Every year ITP partners with different interesting companies ...

Dokladny Dobra Ksiazka Spedzanie wolnego twojego czasu na kasynach internetowych bylo wschodzace na pewno jednego z ...

Following the FDA approval of rilzabrutinib (Wayrilz; Sanofi) for immune thrombocytopenia (ITP), a rare autoimmune disorder, David Kuter, MD, DPhil, highlights the most pressing a ...

Sanofi's BTK inhibitor Wayrilz has become the first drug in the class to be approved by the FDA for immune thrombocytopenia (ITP), a rare autoimmune blood disorder. Wayrilz (rilzabrutinib) has been ...

Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter ...